We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Low-dose 0.01% atropine eye drops safely slowed myopia ...

A study that focused on children aged 5 to 12 years who lived in the United States found no difference between atropine 0.01% and placebo in treating myopia progression. Atropine 0.01% was no more ...

Childhood myopia progression could be treated with low-dose atropine due to the safety and efficacy displayed in this study. The global prevalence of myopia was estimated to be 30% to 34% in 2020 and ...

Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years, ...

Treating U.S. children with an investigational low-dose (0.01%) formulation of atropine eye drops didn't delay worsening of nearsightedness, a randomized clinical trial found. Over 24 months, kids ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The 2-year incidence of myopia was 28.4% in the 0.05% ...

Prior to this research, recent trials conducted primarily in East Asia showed a benefit from .01 percent atropine in slowing myopia. The randomized controlled trial, conducted by the Pediatric Eye ...

LONG BEACH, Calif. -- Low-dose atropine drops showed potential as a noninvasive alternative for managing vitreous floaters, a small retrospective study suggested. A majority of patients who completed ...

According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more effective in controlling myopia progression and axial ...

If you peek into classrooms around the world, a bunch of bespectacled kids peek back at you. In some countries such as China, as much as 80 percent of children are nearsighted. As those kids grow up, ...